Taunton Surgical Centre

Oshawa, Ontario L1J 0C7

2 studies enrolling now · 8 studies all time

What they study most

Colitis, Ulcerative, Crohn Disease, Crohn's Disease, Eosinophilic Esophagitis, Gastroesophageal Reflux Disease (GERD), Ulcerative Colitis

Studies at this site

• A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease — Recruiting now
• A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC) — Recruiting now
• Determination of the Optimal Treatment Target in Ulcerative Colitis — Running, not enrolling
• Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis — Completed
• Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) — Completed
• A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs) — Stopped early
• Long-Term Safety Of PF-00547659 In Ulcerative Colitis — Completed